Jiangxi Sanxin Medtec Co Ltd
Jiangxi Sanxin Medtec Co Ltd is a medical equipment and supplies manufacturer and distributor in China, generating revenue primarily through the sale of medical devices and related healthcare products.
Business. Jiangxi Sanxin Medtec Co Ltd (300453.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Jiangxi Sanxin Medtec Co Ltd (300453.SZ) is a healthcare services and equipment company engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the development and sale of medical devices and related consumables. Headquartered in China, the company is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not disclosed in the available data.
Jiangxi Sanxin Medtec maintains a price-to-book ratio of 3.75 and a price-to-tangible-book ratio of 3.75, indicating a premium valuation relative to its equity base. The company's liquidity position is characterized as medium, with a current ratio of 1.43, suggesting moderate short-term solvency. However, the firm's free cash flow is negative at -5,493,520 CNY, and capital expenditures are substantial at -217,537,090 CNY, indicating ongoing investment in operations.
Profitability metrics show a return on equity of 17.17% and a return on assets of 10.23%, both exceeding the typical thresholds for the medical equipment industry. The company's gross profit of 528,388,010 CNY and operating income of 277,749,000 CNY reflect strong operational efficiency. The debt-to-equity ratio of 0.18 suggests a conservative capital structure with limited leverage.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification, which may expose it to regional market risks. The firm's revenue of 1,500,438,420 CNY is derived primarily from the sale of medical equipment and supplies, with no material diversification across product lines.
Looking ahead, the company is projected to grow revenue from 1,500,438,420 CNY to 1,898,000,000 CNY, a 26.5% increase, driven by expansion in its core medical equipment segment. Analysts expect earnings per share to rise from 0.51 CNY to 0.61 CNY, a 19.6% increase, reflecting improved operational performance.
The company faces a medium liquidity risk due to a negative net cash position after subtracting total debt. Dilution risk is assessed as low, with no significant dilution potential in the near term. The firm's capital expenditures and negative free cash flow suggest a focus on growth through reinvestment rather than shareholder returns.
Recent filings and transcripts indicate the company is expanding its production capacity to meet growing demand in the domestic healthcare market. The firm has also emphasized cost control measures to maintain profitability amid rising input costs.
- Jiangxi Sanxin Medtec is a high-return medical equipment manufacturer with a conservative capital structure.
- The company's valuation multiples suggest a premium pricing relative to its equity base.
- Revenue growth is expected to accelerate in the next fiscal year, driven by expansion in the domestic market.
- The firm's liquidity position is moderate, with a current ratio of 1.43 and negative free cash flow.
- The company's business is concentrated in a single segment, which may increase exposure to market-specific risks.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,61 |
| Revenue | —no estimate | —no estimate | 1,9B CNY |
| Operating income | —no estimate | —no estimate | —no estimate |
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Jiangxi Sanxin Medtec Co Ltd Market data — financials · 2026-05-26
- Jiangxi Sanxin Medtec Co Ltd Market data — analyst estimates · 2026-05-26
Ownership & reference
Leadership
- Zhiping MaoPresident, Director